As we reach the middle of Q3, a look back at the past several months in the healthcare sector indicates certain key trends for the industry and how it is expected to undergo transformation into the future.
Even during a pandemic, innovation and development continues. Pharmaceutical, biotech, healthcare IT and medical device companies are persevering with new and highly advanced mechanisms that will impact outcomes and patient experiences. From specialty drugs to artificial intelligence applications and from 3D printing to virtual reality, the healthcare and life sciences sector is expected to remain an attractive investment area into the future.
Under the demand for COVID-19 testing, contact tracing, and the race to find a vaccine, governments are shifting more of their budgets to healthcare services. Also, in vitro diagnostics testing (IVD) will continue to increase as major players such as CVS and Walgreens build it into their location infrastructures.
Healthcare IT companies have lofty aspirations for enterprise-grade artificial intelligence platforms that can predict pandemics, forecast patient volumes, authenticate reimbursement, and enhance drug management and self-care. Big data in healthcare also continues to draw interest and grow at a high CAGR.
Social distancing and COVID-19 has resulted in the deferral of elective and non-urgent medical procedures. According to a study by JP Morgan:
- 13% of respondents will be postponing elective procedures until there is a vaccine available.
- 15% will be waiting until a treatment is developed.
- 40% said they plan to wait until within a few months of the crisis subsiding.
The use of telehealth services continues to grow in popularity as patients prefer to avoid in-person visits due to pandemic concerns. Prior to the pandemic, telehealth saw slow growth due to a lack of state and federal reimbursement, physicians’ resistance to adopting the new technology, and patient unfamiliarity with virtual visits. COVID-19 and changes to reimbursement have resulted in a massive uptick in telehealth visits over the past several months, growing at a rate of 7.9 percent. Telehealth is also being used more frequently for virtual urgent care and ER visits, as well as for mental health.
The healthcare labor market has been impacted by the current recession and other factors. 1.4 million healthcare jobs were lost as of April but 380,000 jobs were added back in May. Hospitals lost an additional 26,000 jobs. Many clinicians not treating COVID-19 as well as administrative staff are working remotely for the first time in an industry that has typically resisted virtual work. A certain level of virtual work is expected to remain in place into the future.
Because of the global pandemic, many private equity firmshave a heightened focus on their own portfolio businesses. However, the majority are still open to looking at quality opportunities; in addition, strategic buyers such as health systems and hospitals are considering M&A plans in the medium term. Overall, deal volumes are expected to increase between now and H1 of 2021.
Ready to Make a Move?
The M&A experts at Benchmark International are eager to start the conversation about your future, whether it is growing your company, selling your company, maximizing its value, or planning your exit strategy. We are committed to getting you results that fulfill your ambitions and exceed your expectations.READ MORE >>